Johnson & Johnson
(NYSE) JNJ
Johnson & Johnson Financials at a Glance
Market Cap
$549.26B
Revenue (TTM)
$96.36B
Net Income (TTM)
$21.04B
EPS (TTM)
$8.65
P/E Ratio
26.38
Dividend
$5.24
Beta (Volatility)
0.20 (Low)
Dividend
$5.24
Beta (Volatility)
0.20 (Low)
Price
$228.29
Volume
208,038
Open
$226.70
Price
$228.29
Volume
208,038
Open
$226.70
Previous Close
$228.29
Daily Range
$225.90 - $228.65
52-Week Range
$149.04 - $251.71
Estimated Earnings Date
Jul 15, 2026
Dividend
$5.24
Beta (Volatility)
0.20 (Low)
Price
$228.29
Volume
208,038
Open
$226.70
Previous Close
$228.29
Daily Range
$225.90 - $228.65
52-Week Range
$149.04 - $251.71
Estimated Earnings Date
Jul 15, 2026
JNJ News
JNJ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Johnson & Johnson
Industry
Pharmaceuticals
Sector
Health CareEmployees
140,800
CEO
Joaquin Duato, MBA
Website
www.jnj.comHeadquarters
New Brunswick, NJ 08933, US
JNJ Financials
Key Financial Metrics (TTM)
Gross Margin
69%
Operating Margin
27%
Net Income Margin
22%
Return on Equity
26%
Return on Capital
18%
Return on Assets
10%
Earnings Yield
3.79%
Dividend Yield
2.30%
Payout Ratio
59.52%
Stock Overview
Market Cap
$549.26B
Shares Outstanding
2.41B
Volume
208.04K
Avg. Volume
7.68M
Financials (TTM)
Gross Profit
$68.56B
Operating Income
$25.60B
EBITDA
$41.06B
Operating Cash Flow
$24.53B
Capital Expenditure
-$4.83B
Free Cash Flow
$19.70B
Cash & ST Invst.
$20.10B
Total Debt
$47.93B
Johnson & Johnson Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.06B
+9.9%
Gross Profit
$17.20B
+18.3%
Gross Margin
71.49%
N/A
Market Cap
$549.26B
N/A
Market Cap/Employee
$3.98M
N/A
Employees
138,100
N/A
Net Income
$5.24B
-52.4%
EBITDA
$6.40B
-59.0%
Quarterly Fundamentals
Net Cash
$4.59B
+134.1%
Accounts Receivable
$17.72B
+10.6%
Inventory
$14.58B
+15.2%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$17.46B
+25.6%
Return on Assets
10.47%
N/A
Return on Invested Capital
18.08%
N/A
Free Cash Flow
$1.47B
-56.5%
Operating Cash Flow
$2.51B
-39.8%